BIOTEST Trademark

Trademark Overview


On Friday, June 24, 2022, a trademark application was filed for BIOTEST with the United States Patent and Trademark Office. The USPTO has given the BIOTEST trademark a serial number of 76720853. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, September 25, 2024. This trademark is owned by Biotest AG. The BIOTEST trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for treating infectious diseases and diseases of the immune system, namely, proteins and protein preparations made from human blood, blood plasma or blood serum; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, human albumin, coagulation factors and coagulation inhibitors, in particular factor VIII, factor IX, factor X, fibrinogen; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, recombinant proteins, in particular coagulation factors and monoclonal antibodies; pharmaceutical preparations for haematology, immunology, neurology, intensive medicine, transplantation medicine, oncology for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and di...

Biological preparations for use in industry and science, namely, proteins and protein preparations made from human blood, blood plasma or blood serum, in particular human albumin, coagulation factors and immunoglobulins; recombinant proteins for industrial and scientific use; plasma fractions in the nature of biological preparations for industrial and scientific use; excipients for the stabilization of medicines, in particular human albumin for industrial and scientific purposes
biotest

General Information


Serial Number76720853
Word MarkBIOTEST
Filing DateFriday, June 24, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating infectious diseases and diseases of the immune system, namely, proteins and protein preparations made from human blood, blood plasma or blood serum; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, human albumin, coagulation factors and coagulation inhibitors, in particular factor VIII, factor IX, factor X, fibrinogen; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, recombinant proteins, in particular coagulation factors and monoclonal antibodies; pharmaceutical preparations for haematology, immunology, neurology, intensive medicine, transplantation medicine, oncology for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and disorders, cancer and infections; pharmaceutical preparations for preventing and treating viral diseases, for treating diseases of the immune system, for treating autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying and toxin-neutralizing medicines
Pseudo MarkBIO TEST
Goods and ServicesBiological preparations for use in industry and science, namely, proteins and protein preparations made from human blood, blood plasma or blood serum, in particular human albumin, coagulation factors and immunoglobulins; recombinant proteins for industrial and scientific use; plasma fractions in the nature of biological preparations for industrial and scientific use; excipients for the stabilization of medicines, in particular human albumin for industrial and scientific purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiotest AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressDreieich 63303
DE

Party NameBiotest AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Wednesday, June 22, 2022REQUEST FOR TRANSFORMATION PROCESSED - TOTAL
Friday, June 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2022APPLICATION FILING RECEIPT MAILED
Monday, April 10, 2023ASSIGNED TO EXAMINER
Thursday, April 13, 2023NON-FINAL ACTION WRITTEN
Thursday, April 13, 2023NON-FINAL ACTION MAILED
Thursday, July 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 24, 2024SOU EXTENSION 1 FILED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, August 15, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, August 15, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, August 15, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, August 15, 2024PETITION TO REVIVE-GRANTED
Wednesday, September 25, 2024SOU EXTENSION 1 GRANTED
Wednesday, September 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED